Terms: = Prostate cancer AND ETV1, DKFZp781L0674, 2115, ENSG00000006468, ER81, MGC120533, MGC104699, MGC120534 AND Prognosis
8 results:
1. The Value of Combined Detection of Serum PSA, MALAT1 and TMPRSS2-etv1 in Evaluating the Progress and prognosis of prostate cancer.
Zhao G; Pan Z; Wang P
Arch Esp Urol; 2023 Oct; 76(8):555-562. PubMed ID: 37960954
[TBL] [Abstract] [Full Text] [Related]
2. Development and characterization of an etv1 rabbit monoclonal antibody for the immunohistochemical detection of etv1 expression in cancer tissue specimens.
Schafer C; Young D; Singh H; Jayakrishnan R; Banerjee S; Song Y; Dobi A; Petrovics G; Srivastava S; Srivastava S; Sesterhenn IA; Chesnut GT; Tan SH
J Immunol Methods; 2023 Jul; 518():113493. PubMed ID: 37196930
[TBL] [Abstract] [Full Text] [Related]
3. A novel PTPRZ1-etv1 fusion in gliomas.
Matjašič A; Zupan A; Boštjančič E; Pižem J; Popović M; Kolenc D
Brain Pathol; 2020 Mar; 30(2):226-234. PubMed ID: 31381204
[TBL] [Abstract] [Full Text] [Related]
4. Development of Castration Resistant prostate cancer can be Predicted by a DNA Hypermethylation Profile.
Angulo JC; Andrés G; Ashour N; Sánchez-Chapado M; López JI; Ropero S
J Urol; 2016 Mar; 195(3):619-26. PubMed ID: 26551297
[TBL] [Abstract] [Full Text] [Related]
5. Overexpression of ETV4 is associated with poor prognosis in prostate cancer: involvement of uPA/uPAR and MMPs.
Qi M; Liu Z; Shen C; Wang L; Zeng J; Wang C; Li C; Fu W; Sun Y; Han B
Tumour Biol; 2015 May; 36(5):3565-72. PubMed ID: 25544710
[TBL] [Abstract] [Full Text] [Related]
6. Detection of TMPRSS2 gene deletions and translocations in carcinoma, intraepithelial neoplasia, and normal epithelium of the prostate by direct fluorescence in situ hybridization.
Zhang S; Pavlovitz B; Tull J; Wang Y; Deng FM; Fuller C
Diagn Mol Pathol; 2010 Sep; 19(3):151-6. PubMed ID: 20736744
[TBL] [Abstract] [Full Text] [Related]
7. Molecular characterisation of ERG, etv1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer.
Reid AH; Attard G; Ambroisine L; Fisher G; Kovacs G; Brewer D; Clark J; Flohr P; Edwards S; Berney DM; Foster CS; Fletcher A; Gerald WL; Møller H; Reuter VE; Scardino PT; Cuzick J; de Bono JS; Cooper CS;
Br J Cancer; 2010 Feb; 102(4):678-84. PubMed ID: 20104229
[TBL] [Abstract] [Full Text] [Related]
8. Hormone-sensitive prostate cancer: a case of ETS gene fusion heterogeneity.
Attard G; Jameson C; Moreira J; Flohr P; Parker C; Dearnaley D; Cooper CS; de Bono JS
J Clin Pathol; 2009 Apr; 62(4):373-6. PubMed ID: 19066166
[TBL] [Abstract] [Full Text] [Related]
